Clinical Trials Browser

Phase 1/2 × OTHER × oregovomab × Clear all

NCT03100006 2022-06-13

ORION-01

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial

NCT04620954 2021-12-01

ORION-02

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial